Acadia Pharmaceuticals Inc. (ACAD) shares outstanding

Shares outstanding · fiscal 2025
169.92M

Acadia Pharmaceuticals Inc. (ACAD) had 169.92M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.1% higher than the 166.36M of fiscal 2024. Figures as of 18 Nov 2026, 11:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
169.92M
Change on fiscal 2024
+2.1%
Growth, 5 years
+1.6% a year
Highest on record
169.92Mfiscal 2025
Lowest on record
37.48Mfiscal 2009
Fiscal years on record
102009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Acadia Pharmaceuticals Inc. shares outstanding, in more detail

The market data feed counts 172.83M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 1.6% a year. Across the 10 fiscal years on record (2009–2025), the highest was 169.92M in fiscal 2025 and the lowest 37.48M in fiscal 2009.

History · 10 fiscal years

Shares outstanding by fiscal year

Acadia Pharmaceuticals Inc. shares outstanding, year by year

Acadia Pharmaceuticals Inc. (ACAD) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025169.92M 2.1% up
2024166.36M 1.6% up
2023163.82M 1.3% up
2022161.68M 1.1% up
2021159.88M 1.6% up
2020157.31M—
201255.12M 5.6% up
201152.18M 34.8% up
201038.72M 3.3% up
200937.48M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on ACAD

Acadia Pharmaceuticals Inc., figure by figure

Acadia Pharmaceuticals Inc. (ACAD) overview: price, valuation and scorecard

Acadia Pharmaceuticals Inc. shares outstanding: questions and answers

How many shares does Acadia Pharmaceuticals Inc. have?

Acadia Pharmaceuticals Inc. (ACAD) had 169.92M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.1% higher than the 166.36M of fiscal 2024. The market data feed counts 172.83M shares outstanding today.

What is the growth rate of Acadia Pharmaceuticals Inc.'s diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 1.6% a year.

What are the highest and lowest diluted share count figures on record for Acadia Pharmaceuticals Inc.?

Across the 10 fiscal years on record (2009–2025), the highest was 169.92M in fiscal 2025 and the lowest 37.48M in fiscal 2009.

How is Acadia Pharmaceuticals Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Acadia Pharmaceuticals Inc. it is on record here for 10 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Acadia Pharmaceuticals Inc. (ACAD) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/ACAD/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.